Brief: Prometheus Biosciences Announces Upsized Pricing Of IPO
12/03/2021 03:28
March 12 (Reuters) - Prometheus Biosciences Inc RXDX.O :
* ANNOUNCES UPSIZED PRICING OF INITIAL PUBLIC OFFERING
* PRICING OF ITS UPSIZED INITIAL PUBLIC OFFERING AT $19.00
PER
SHARE
Source text for Eikon: ID:nPnccVZFna
Further company coverage: RXDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prometheus Biosciences
See all newsBrief: Prometheus Biosciences - Completed Merger Of Splash Merger Sub, Unit Of Merck & Co
Analysis: Amgen's antitrust woes spur wider pharmaceutical deal fears
William Blair sees FTC suit on Amgen-Horizon deal weighing on biotech M&A sentiment
FTC scrutiny to block Amgen-Horizon deal drags down Seagen, Prometheus
Brief: Prometheus Biosciences Reports First Quarter 2023 Financial Results